
Caplin Point Laboratories Ltd. share price
NSE: CAPLIPOINT · Healthcare
₹2,346.80 -1.75%
Closing price data, updated 17 Nov 2026. 52-week range: -21.5% from high, +56.4% above low.
Price₹2,346.80
Market cap₹17,838 Cr
P/E25.9
P/B4.57
ROE19.9%
ROCE22.0%
Debt / equity0.00
Dividend yield0.00%
EPS₹90.64
Book value₹513.40
Operating margin32.0%
Dipscan score64 / 100
Share: WhatsAppX / TwitterTelegram
Caplin Point Laboratories Ltd. shareholding pattern
As of Sep 2026: Promoters 70.57%, FIIs 5.73%, DIIs 2.20%, Government 0.00%, Public 14.94%, Others 6.56%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 70.57% | 70.57% | 70.57% | 70.57% | 70.57% | 70.56% |
| FIIs | 5.73% | 5.75% | 6.15% | 6.59% | 6.51% | 6.17% |
| DIIs | 2.20% | 2.49% | 2.14% | 2.05% | 2.10% | 2.22% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 14.94% | 14.62% | 14.46% | 14.13% | 14.20% | 14.32% |
| Others | 6.56% | 6.56% | 6.68% | 6.65% | 6.61% | 6.73% |
| No. of Shareholders | 103,386 | 94,385 | 93,896 | 93,705 | 93,753 | 94,169 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| -1.75% | -1.50% | +0.37% | -6.12% | +15.96% | +20.48% |
Growth
| Sales growth, 3 years | +14.3% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +19.4% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | – |
| Latest quarter profit vs last year | – |
Strengths and weaknesses
Strengths
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 21.4% CAGR over last 5 years
- Company's median sales growth is 19.9% of last 10 years
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Caplin Point Laboratories Ltd.?
Caplin Point Laboratories Ltd. (CAPLIPOINT) last closed at ₹2,346.80 (-1.75% on the day).
What is the market cap of Caplin Point Laboratories Ltd.?
About ₹17,838 Cr.
What is the P/E ratio of Caplin Point Laboratories Ltd.?
The price-to-earnings ratio is 25.9, and return on equity is 19.9%.
Figures are calculated from company results and exchange prices and are for information only.